Abstract
The clinical presentation and neurobiology of mild traumatic brain injury (mTBI) - also referred to as concussion - are complex and multifaceted, and interrelationships between neurobiological measures derived from neuroimaging are poorly understood. This study applied machine learning (ML) to multimodal whole-brain functional connectomes from magnetoencephalography (MEG) and functional magnetic resonance imaging (fMRI), and structural connectomes from diffusion tensor imaging (DTI) in a test of discriminative accuracy in cases of mTBI. Resting state MEG (amplitude envelope correlations), fMRI (BOLD correlations), and DTI (fractional anisotropy, FA; streamline count, SC) connectome data was acquired in 26 controls without mTBI (all male; 27.6 ± 4.7 years) and 24 participants with mTBI (all male; 29.7 ± 6.7 years) in the acute-subacute phase of injury. ML with data fusion was used to optimally identify modalities and brain features for discriminating individuals with mTBI from those without. Univariate group differences were only found for MEG functional connectivity, while no differences were found for fMRI or DTI. Functional connectivity (fMRI and MEG) showed robust unimodal classification accuracy for mTBI, followed by structural connectivity (DTI), where FA showed marginally better classification performance than SC, but SC outperformed FA in data interpretation and fusion. Perfect, unsupervised separation of participants with and without mTBI was achieved through participant fusion maps featuring all three data modalities. Finally, the MEG-only full feature fusion map showed group differences, and this effect was eliminated upon integrating DTI and fMRI datasets. The markers identified here align well with prior multimodal findings in concussion and highlight modality-specific considerations for their use in understanding network abnormalities of mTBI.
Competing Interest Statement
BTD is Chief Science Officer at MYndspan Ltd. The remaining authors report no competing interests.
Funding Statement
This research was in-part funded by awards to BTD from the Department of National Defence, and their Innovation for Defence Excellence and Security (IDEaS) program, Defence Research and Development Canada (DRDC).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by Sunnybrook and the Hospital for Sick Children Research Ethics Boards.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study were funded through defence contracts, and given the nature of the work, are not publicly available.
